Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Ginecol Obstet Mex ; 80(3): 218-23, 2012 Mar.
Artigo em Espanhol | MEDLINE | ID: mdl-22812178

RESUMO

Perinatal hemolytic disease occurs secondary to a hemolytic phenomenon of immune origin resulting in fetal or neonatal anemia. A 38-year-old pregnant woman was referred to the Department of high risk Obstetrics, Hospital Universitario La Paz Madrid because of presenting a dichorionic diamniotic twin pregnancy spontaneously, pre-pregnancy diabetes poorly controlled and severe alloinmunization anti-D. Her first pregnancy ended in a normal delivery at term; in the period of 4 years, she has three newborn with 36, 34 and 40 weeks respectively, who die with a week of life. After that, two intrauterine fetal death occur at 26 weeks of gestation. The patient who is RhD negative, suffers anti-D inmunization with a antibody titration of 1/1024 with 14 weeks of gestation. Twelve plasmapheresis, eight doses of anti-D inmunoglobulins and intrauterine transfusions has been the treatment received. A severe anemia is found during the ultrasound control of the middLe cerebral artery peak systolic velocity in both twins since the 16th week. It remains stable thanks to the treatment. Finally at the 28th week of gestation, pregnancy is terminated with a cesarean section. The twins are born alive and premature, but with good general state. The measurement of the middle cerebral artery peak systolic velocity predicts moderate-severe fetal anemia cases, which are the most important in the clinical management because of the need of active treatment or finish the pregnancy.


Assuntos
Doenças em Gêmeos/terapia , Gravidez de Gêmeos , Isoimunização Rh/terapia , Adulto , Anemia/diagnóstico por imagem , Anemia/embriologia , Anemia/etiologia , Cesárea , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/dietoterapia , Diabetes Mellitus Tipo 2/tratamento farmacológico , Doenças em Gêmeos/diagnóstico por imagem , Doenças em Gêmeos/imunologia , Feminino , Sangue Fetal , Doenças Fetais/etiologia , Idade Gestacional , Humanos , Artéria Cerebral Média/diagnóstico por imagem , Artéria Cerebral Média/embriologia , Plasmaferese , Gravidez , Complicações na Gravidez/dietoterapia , Complicações na Gravidez/tratamento farmacológico , Gravidez de Alto Risco , Isoimunização Rh/diagnóstico por imagem , Isoimunização Rh/imunologia , Sístole , Gêmeos Dizigóticos , Ultrassonografia , gama-Globulinas/uso terapêutico
2.
Eur J Obstet Gynecol Reprod Biol ; 127(1): 68-72, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16229935

RESUMO

OBJECTIVE: Retrospective evaluation of pelvic arterial embolization for the treatment of severe post-partum hemorrhage. METHODS: Data were collected, from our departmental clinical records, on all patients with life-threatening post-partum hemorrhage managed with arterial embolization between January 2001 and December 2003. RESULTS: During the period analyzed, there were 29,119 deliveries in our institution. Of these, 27 patients underwent pelvic arterial embolization to control severe hemorrhaging despite conservative management. Of the 27 patients, 22 (81.5%) had a vaginal delivery and 5 had a caesarean section. The major indication for embolization was uterine atony (15 women). Disseminated intravascular coagulation developed in 20 cases (74.1%). There were eight cases (29.6%) who underwent hysterectomy, seven of them pre-embolization. The most frequent vessel embolized was the uterine artery (13 cases; 38.3%). One patient (3.7%) presented complications related to the procedure. The success rate was 96.3%. CONCLUSION: Pelvic arterial embolization is a good therapeutic choice for severe post-partum hemorrhage refractory to conservative treatment measures.


Assuntos
Parto Obstétrico , Embolização Terapêutica/métodos , Hemorragia Pós-Parto/terapia , Adulto , Artérias , Feminino , Humanos , Histerectomia , Pelve/irrigação sanguínea , Gravidez , Estudos Retrospectivos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA